Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1976 1
1986 4
1987 1
1989 2
1990 1
1991 1
1992 5
1993 2
1994 1
1995 2
1998 2
1999 1
2000 2
2001 1
2004 1
2005 2
2006 1
2007 4
2008 4
2009 6
2010 7
2011 6
2012 7
2013 4
2014 7
2015 12
2016 12
2017 9
2018 15
2019 13
2020 10
2021 8
2022 8
2023 9
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

158 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Matulonis UA, Lorusso D, Oaknin A, Pignata S, Dean A, Denys H, Colombo N, Van Gorp T, Konner JA, Marin MR, Harter P, Murphy CG, Wang J, Noble E, Esteves B, Method M, Coleman RL. Matulonis UA, et al. Among authors: murphy cg. J Clin Oncol. 2023 May 1;41(13):2436-2445. doi: 10.1200/JCO.22.01900. Epub 2023 Jan 30. J Clin Oncol. 2023. PMID: 36716407 Free PMC article. Clinical Trial.
Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I.
Moore KN, Oza AM, Colombo N, Oaknin A, Scambia G, Lorusso D, Konecny GE, Banerjee S, Murphy CG, Tanyi JL, Hirte H, Konner JA, Lim PC, Prasad-Hayes M, Monk BJ, Pautier P, Wang J, Berkenblit A, Vergote I, Birrer MJ. Moore KN, et al. Among authors: murphy cg. Ann Oncol. 2021 Jun;32(6):757-765. doi: 10.1016/j.annonc.2021.02.017. Epub 2021 Mar 2. Ann Oncol. 2021. PMID: 33667670 Free article. Clinical Trial.
Reply to Z.R. McCaw et al.
Matulonis UA, Lorusso D, Oaknin A, Pignata S, Dean A, Denys H, Colombo N, Van Gorp T, Konner JA, Marin MR, Harter P, Murphy CG, Wang J, Noble E, Esteves B, Method M, Coleman RL. Matulonis UA, et al. Among authors: murphy cg. J Clin Oncol. 2023 Oct 10;41(29):4705-4706. doi: 10.1200/JCO.23.00752. Epub 2023 Aug 3. J Clin Oncol. 2023. PMID: 37535884 No abstract available.
CDK4/6 inhibitors in breast cancer.
Dukelow T, Kishan D, Khasraw M, Murphy CG. Dukelow T, et al. Among authors: murphy cg. Anticancer Drugs. 2015 Sep;26(8):797-806. doi: 10.1097/CAD.0000000000000249. Anticancer Drugs. 2015. PMID: 26053278 Review.
The Role of CDK4/6 Inhibitors in Breast Cancer.
Murphy CG. Murphy CG. Curr Treat Options Oncol. 2019 May 18;20(6):52. doi: 10.1007/s11864-019-0651-4. Curr Treat Options Oncol. 2019. PMID: 31101994 Review.
Endoscopic Management of Gluteus Medius Tendon Tears.
Thaunat M, Noël E, Nové-Josserand L, Murphy CG, Sbiyaa M, Sonnery-Cottet B. Thaunat M, et al. Among authors: murphy cg. Sports Med Arthrosc Rev. 2016 Mar;24(1):11-8. doi: 10.1097/JSA.0000000000000082. Sports Med Arthrosc Rev. 2016. PMID: 26752773 Review.
HER2-positive breast cancer: beyond trastuzumab.
Murphy CG, Fornier M. Murphy CG, et al. Oncology (Williston Park). 2010 Apr 30;24(5):410-5. Oncology (Williston Park). 2010. PMID: 20480738 Free article. Review.
The Role of CDK4/6 Inhibition in Breast Cancer.
Murphy CG, Dickler MN. Murphy CG, et al. Oncologist. 2015 May;20(5):483-90. doi: 10.1634/theoncologist.2014-0443. Epub 2015 Apr 15. Oncologist. 2015. PMID: 25876993 Free PMC article. Review.
158 results